Reprint

Actinobacteria and Myxobacteria

Important Resources for Novel Antibiotics

Edited by
December 2020
271 pages
  • ISBN978-3-03943-529-6 (Hardback)
  • ISBN978-3-03943-530-2 (PDF)

This is a Reprint of the Special Issue Actinobacteria and Myxobacteria—Important Resources for Novel Antibiotics that was published in

Biology & Life Sciences
Environmental & Earth Sciences
Medicine & Pharmacology
Summary
Bacterial infections cause millions of deaths globally, particularly in children and the elderly, and four of the 10 leading causes of death are infectious diseases in low- and middle-income countries. The continuous use of antibiotics has resulted in multi-resistant bacterial strains all over the world, such as Community-associated Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamases (ESBLs), and, as expected, hospitals have become breeding grounds for human-associated microorganisms, especially in critical care units.